Earticle

현재 위치 Home

바이오의약 및 약물전달

A Novel Monoclonal Antibody against TRAIL Receptor 1 Induces Apoptotic Cell Death in Various Cancer Cells

첫 페이지 보기
  • 발행기관
    한국생물공학회 바로가기
  • 간행물
    한국생물공학회 학술대회 바로가기
  • 통권
    2009 추계학술대회 및 국제심포지움 (2009.11)바로가기
  • 페이지
    pp.251-251
  • 저자
    Eun-Sil SUNG, Kyung-Jin PARK, Seung-Hyun LEE, Yoon-Seon JANG, Sang-Koo PARK, Yoo-Hoi PARK, Won-Jae KWAG, Myung-Hee KWON, Yong-Sung KIM
  • 언어
    영어(ENG)
  • URL
    https://www.earticle.net/Article/A115319

※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.

원문정보

초록

영어
The proapoptotic tumor necrosis factor–related apoptosis inducing ligand (TRAIL) receptors death
receptor (DR) 4 and DR5 are attractive targets to develop the receptorspecificagonistic monoclonal
antibodies (mAb) as anticancer agents because of their tumor-selective cell death–inducing
activity. Here, we report a novel agonistic mAb, AY4, raised against human DR4 in mice. ELISA
analysis revealed that AY4 specifically bound to DR4 withoutcompetition with TRAIL for the
binding. Despite distinct binding regions of AY4 on DR4 from those of TRAIL, AY4 as a single
agent induced caspase-dependent apoptotic cell death of several tumor types through the extrinsic and/or intrinsic pathways without substantial cytotoxicity to normal human hepatocytes. Further, the AY4-sensitive cells followed the same cell death characteristics classified as type I and type II cells by the response to TRAIL,suggesting that the cell death profiles in responses to DR4 and/or DR5 stimulation are determined by the downstream signaling of the receptor rather than the kind of receptor. Noticeably, AY4 efficiently induced cell death of Jurkat cells, which have been reported to be resistant to other anti-DR4 agonistic mAbs, most likely due to the unique epitope property of AY4. In vivo administration of AY4 significantly inhibited tumor growth of human non–small cell lung carcinoma preestablished in athymic nude mice. Conclusively, our results provide further insight into the DR4-mediated cell death signaling and potential use of AY4 mAb as an anticancer therapeutic agent, particularly for DR4-responsive tumor types.

키워드

apoptosis TRAIL DR4 caspase

저자

  • Eun-Sil SUNG [ Department of Molecular Science and Technology, Ajou University ]
  • Kyung-Jin PARK [ Department of Molecular Science and Technology, Ajou University ]
  • Seung-Hyun LEE [ Department of Molecular Science and Technology, Ajou University ]
  • Yoon-Seon JANG [ Biotech Laboratory, Yuhan Research Institute, Yuhan Corporation, Yongin 446-902. ]
  • Sang-Koo PARK [ Biotech Laboratory, Yuhan Research Institute, Yuhan Corporation, Yongin 446-902. ]
  • Yoo-Hoi PARK [ Biotech Laboratory, Yuhan Research Institute, Yuhan Corporation, Yongin 446-902. ]
  • Won-Jae KWAG [ Biotech Laboratory, Yuhan Research Institute, Yuhan Corporation, Yongin 446-902. ]
  • Myung-Hee KWON [ Department of Microbiology, Ajou University School of Medicine, Suwon 442-721. ]
  • Yong-Sung KIM [ Department of Molecular Science and Technology, Ajou University, Suwon 443-749. ]

참고문헌

자료제공 : 네이버학술정보

간행물 정보

발행기관

  • 발행기관명
    한국생물공학회 [The Korean Society for Biotechnology and Bioengineering]
  • 설립연도
    1984
  • 분야
    공학>생물공학
  • 소개
    이 법인은 생물 공학의 발전과 보급에 이바지하고, 회원 상호 간의 연구 협력과 친목을 도모함을 목적으로 한다 1. 생물공학 분야의 발전을 위한 연구 협력 2. 생물공학의 실용화를 촉진시키기 위한 산학 협동 3. 학술연구 발표회, 강연회, 연수회 등 학술활동의 개최 4. 국,영문 학술지,소식지,학술회의 Proceedings 및 학술도서의 발간 5. 생물공학 발전을 위한 정책 건의 6. 기타 국제 교류 등 본 학회의 목적 달성을 위한 제반 활동

간행물

  • 간행물명
    한국생물공학회 학술대회
  • 간기
    반년간
  • 수록기간
    1985~2013
  • 십진분류
    KDC 476 DDC 576

이 권호 내 다른 논문 / 한국생물공학회 학술대회 2009 추계학술대회 및 국제심포지움

    피인용수 : 0(자료제공 : 네이버학술정보)

    함께 이용한 논문 이 논문을 다운로드한 분들이 이용한 다른 논문입니다.

      페이지 저장